EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Positive inotropic effects of glucose-dependent insulinotropic polypeptide in the human atrium and the mouse atrium

J Neumann, B Hofmann, U Gergs

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-025-04485-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von J Neumann und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, 06097, Halle (Saale), Ge…. Hauptthemen laut MEDLINE: Gastric Inhibitory Polypeptide, Heart Atria, Myocardial Contraction, Cardiotonic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Martin-Luther-Universität Halle-Wittenberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucose-dependent insulinotropic polypeptide formerly called gastrin inhibitory peptide (GIP), a peptide composed of 42 amino acids, is formed in duodenal and jejunal cells. GIP acts via GIP receptors (GIPR). GIPR can stimulate adenylyl cyclases (AC) and increase intracellular cyclic adenosine-3´,5´-monophosphate (cAMP) levels. The physiological role of GIPR in the human heart is not fully understood. Thence, force of contraction (FOC) was studied in isolated electrically driven (1 Hz) human right atrial preparations from patients undergoing bypass surgery due to severe coronary heart disease. We noted that in paced human atrium, GIP increased FOC. This effect was reduced by a GIPR-antagonist (ProGIP). In the presence of 0.1 µM cilostamide, a phosphodiesterase (PDE) 3 inhibitor, the positive inotropic effects (PIE) of GIP were more potent and efficient to raise FOC. Up to 100 nM GIP failed to heighten the spontaneous beating rate in mouse right atrial preparations, but increased FOC in electrically driven left atrial mouse preparations but only in the presence of a PDE 4 inhibitor (100 nM rolipram). We conclude that the human atrium and the mouse atrium contain functional GIPR with respect to FOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastric Inhibitory PolypeptideHeart AtriaMyocardial ContractionCardiotonic AgentsAnimalsHumansMaleReceptors, Gastrointestinal HormoneMiceFemaleAgedMiddle Aged

Stichwörter der Autor:innen

GIPGIP receptorHuman atriumMouse atrium

Substanzen

Gastric Inhibitory PolypeptideReceptors, Gastrointestinal Hormonegastric inhibitory polypeptide receptorCardiotonic Agents

Autor:innen und Institutionen

  • Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, 06097, Halle (Saale), Germany. joachim.neumann@medizin.uni-halle.de.
  • Department of Cardiac Surgery, Mid-German Heart Centre, University Hospital Halle, Ernst-Grube-Straße 40, 06097, Halle (Saale), Germany.
  • Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, 06097, Halle (Saale), Germany.

Förderung

  • Martin-Luther-Universität Halle-Wittenberg

Zitieren

APA

Neumann, J., Hofmann, B., & Gergs, U. (2026). Positive inotropic effects of glucose-dependent insulinotropic polypeptide in the human atrium and the mouse atrium. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04485-1

Vancouver

Neumann J, Hofmann B, Gergs U. Positive inotropic effects of glucose-dependent insulinotropic polypeptide in the human atrium and the mouse atrium. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04485-1

BibTeX
@article{Neumann2026,
  author = {Neumann, J and Hofmann, B and Gergs, U},
  title = {Positive inotropic effects of glucose-dependent insulinotropic polypeptide in the human atrium and the mouse atrium},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-025-04485-1}
}
Kostenlos starten →